DigestAI news desk

Cut through the AI noise.

Model

Claude Science news

The latest Claude Science news, : Anthropic uses Claude to map bacteriophage vault protein at 3.2 Å resolution.

Claude Science is an AI platform and workbench used by Novo Nordisk to accelerate drug discovery and research workflows. Recent coverage highlights this strategic partnership, which coincided with a rise in Novo’s share price. The platform is part of broader Anthropic initiatives, including a Life Sciences Verification Program that provides vetted biology teams access to frontier models under permissive safeguards.

9 stories mentioning Claude Science since 18 September 2026, newest first, each with its sources and discussion. Follow to see new ones on your front page.

  1. Research new

    Anthropic uses Claude to map bacteriophage vault protein at 3.2 Å resolution

    Anthropic announced on November 4, 2026, that its AI model Claude helped map the structure of a bacteriophage-derived vault protein at 3.2 angstroms resolution. The team produced vault-like particles in E. coli from 44…

    1 source
    Unite.AI
  2. Business & Funding new

    Anthropic details drug development work with six partners and acquires Mithril

    Anthropic disclosed deep research partnerships with six life-sciences organizations — BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group — and said it…

    3 sources primary source HN 39
    finance.yahoo.comanthropic.comUnite.AI
  3. Nvidia and University of Washington unveil open-source protein design model RFD4-Proteina

    Nvidia and the University of Washington School of Medicine Institute for Protein Design have released RFD4-Proteina, an open‑source generative model built on Nvidia’s BioNeMo platform. The developers say the model…

    2 sources
    timesofindia.indiatimes.comgenengnews.com
  4. Research new

    Anthropic's Claude autonomously designs protein binders against scorpion neurotoxins

    Anthropic's Claude, in collaboration with Citrini Research, autonomously designed protein minibinders targeting five scorpion neurotoxins from four species, generating 318,484 candidate designs over a 24-hour…

    5 sources primary source HN 41
    The Verge AInote.comvectorwire.aiThe Decoder +1 more
  5. Business & Funding new

    OpenAI acquires Orchestra Bio to expand Rosalind life sciences tools

    OpenAI announced on October 20, 2026, that it has acquired Orchestra Bio, a startup founded around 2022 that builds AI agents to help pharmaceutical companies manage drug development programs. The Orchestra team and…

    19 sources
    finance.yahoo.comThe Decodernote.comvectorwire.ai +7 more
  6. Business & Funding new

    Anthropic invests $100 million to train 10,000 engineers by end of 2027

    Anthropic launched the Claude Frontier Academy on October 2, 2026, backed by a $100 million commitment to train 10,000 Frontier Deployed Engineers by the end of 2027. The program’s first cohort includes engineers from…

    15 sources primary source
    note.comthedailystar.netCNBC TechnologyUnite.AI +7 more
  7. Policy & Regulation new

    Anthropic partners with Novo Nordisk to use Claude models in drug discovery

    Anthropic has partnered with Novo Nordisk to use Claude models and Claude Science in Novo's research and development workflows, focusing on scientific problems where AI can have the greatest impact. Novo will also use…

    3 sources
    finance.yahoo.compopularmechanics.comnote.com
  8. Enterprise & Industry new

    WHO and CEPI deploy Anthropic's Claude to combat Ebola outbreak in DRC

    Health organizations combating an outbreak of the Bundibugyo strain of Ebolavirus in the Democratic Republic of the Congo are using Anthropic's Claude to accelerate data analysis and response operations. The outbreak…

    1 source primary source
    anthropic.com
  9. Business & Funding new

    Novo partners with Anthropic on Claude Science platform, shares up 3.55%

    Novo Nordisk announced a strategic collaboration with Anthropic to use the Claude Science platform for accelerating pharmaceutical research and development. The partnership was disclosed alongside a 3.55% rise in…

    1 source
    blockonomi.com

Questions about Claude Science

What is the latest Claude Science news?

As of 4 November 2026: Anthropic uses Claude to map bacteriophage vault protein at 3.2 Å resolution. Anthropic announced on November 4, 2026, that its AI model Claude helped map the structure of a bacteriophage-derived vault protein at 3.2 angstroms resolution.

What is Claude Science?

Claude Science is an AI platform and workbench used by Novo Nordisk to accelerate drug discovery and research workflows. Recent coverage highlights this strategic partnership, which coincided with a rise in Novo’s share price. The platform is part of broader Anthropic initiatives, including a Life Sciences Verification Program that provides vetted biology teams access to frontier models under permissive safeguards.